| Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide E Topkan, S Topuk, E Oymak, C Parlak, B Pehlivan American journal of clinical oncology 35 (3), 284-289, 2012 | 73 | 2012 |
| Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses C Onal, G Arslan, E Topkan, B Pehlivan, M Yavuz, E Oymak, A Yavuz Journal of Experimental & Clinical Cancer Research 28 (1), 1-10, 2009 | 73 | 2009 |
| Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy C Onal, M Reyhan, C Parlak, OC Guler, E Oymak International Journal of Gynecologic Cancer 23 (6), 2013 | 55 | 2013 |
| Dosimetric comparison of the field-in-field technique and tangential wedged beams for breast irradiation C Onal, A Sonmez, G Arslan, E Oymak, A Kotek, E Efe, S Sonmez, ... Japanese journal of radiology 30 (3), 218-226, 2012 | 55 | 2012 |
| Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group … P Hurmuz, C Onal, G Ozyigit, S Igdem, B Atalar, H Sayan, Z Akgun, M Kurt, ... Strahlentherapie und Onkologie 196 (11), 1034-1043, 2020 | 36 | 2020 |
| Evaluation of field-in-field technique for total body irradiation C Onal, A Sonmez, G Arslan, S Sonmez, E Efe, E Oymak International Journal of Radiation Oncology* Biology* Physics 83 (5), 1641-1648, 2012 | 32 | 2012 |
| Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients C Onal, G Ozyigit, E Oymak, OC Guler, B Tilki, P Hurmuz, F Akyol European Journal of Nuclear Medicine and Molecular Imaging 48 (11), 3683-3692, 2021 | 27 | 2021 |
| Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients during abiraterone/enzalutamide treatment C Onal, F Kose, G Ozyigit, S Aksoy, E Oymak, S Muallaoglu, OC Guler, ... The Prostate 81 (9), 543-552, 2021 | 25 | 2021 |
| Isolated Mediastinal Lymph Node False Positivity of [18F]-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography in Patients With Cervical Cancer C Onal, E Oymak, A Findikcioglu, M Reyhan International Journal of Gynecologic Cancer 23 (2), 2013 | 24 | 2013 |
| Oligometastatic bone disease in castration-sensitive prostate cancer patients treated with stereotactic body radiotherapy using 68Ga-PSMA PET/CT: TROD 09-004 study C Onal, G Ozyigit, Z Akgun, B Atalar, S Igdem, E Oymak, F Agaoglu, ... Clinical Nuclear Medicine 46 (6), 465-470, 2021 | 20 | 2021 |
| Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients C Onal, G Ozyigit, OC Guler, P Hurmuz, N Torun, M Tuncel, Y Dolek, ... Radiotherapy and Oncology 151, 222-227, 2020 | 20 | 2020 |
| Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis C Onal, M Gultekin, E Oymak, OC Guler, MT Yilmaz, SY Sari, BA Yildirim, ... International Journal of Gynecologic Cancer 30 (6), 2020 | 18 | 2020 |
| Correlation of conventional and conformal plan parameters for predicting radiation pneumonitis in patients treated with breast cancer C Onal, E Oymak, A Kotek, E Efe, G Arslan Journal of Breast Cancer 15 (3), 320-328, 2012 | 15 | 2012 |
| Bilateral choroidal metastases from lung adenocarcinoma: a case report H Ergenc, A Onmez, E Oymak, R Tanriseven, E Celik, FE Onmez, ... Case Reports in Oncology 9 (3), 530-536, 2016 | 13 | 2016 |
| Retrospective correlation of 68ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy C Onal, N Torun, E Oymak, OC Guler, M Reyhan, AF Yapar Annals of Nuclear Medicine 34 (6), 388-396, 2020 | 11 | 2020 |
| The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive … C Onal, G Erbay, OC Guler, E Oymak Radiotherapy and Oncology 173, 285-291, 2022 | 8 | 2022 |
| Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy C Onal, S Yuce Sari, G Yavas, E Oymak, SD Birgi, E Yigit, OC Guler, ... Acta Oncologica 60 (9), 1154-1160, 2021 | 8 | 2021 |
| Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate BA Yildirim, C Onal, F Kose, E Oymak, AM Sedef, AA Besen, S Aksoy, ... Strahlentherapie und Onkologie 195 (10), 872-881, 2019 | 8 | 2019 |
| Primary solitary extramedullary plasmacytoma of the tongue C Onal, E Oymak, A Uguz, M Ergin Ear, Nose & Throat Journal 91 (7), 292-295, 2012 | 8 | 2012 |
| Clinical parameters and nomograms for predicting lymph node metastasis detected with 68Ga‐PSMA‐PET/CT in prostate cancer patients candidate to definitive … C Onal, G Ozyigit, E Oymak, OC Guler, P Hurmuz, B Tilki, M Reyhan, ... The Prostate 81 (10), 648-656, 2021 | 7 | 2021 |
